Hartline Investment Corp bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 2,115 shares of the semiconductor company’s stock, valued at approximately $839,000.
Several other large investors have also recently made changes to their positions in the business. Sankala Group LLC purchased a new stake in shares of Synopsys in the 4th quarter worth approximately $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Synopsys during the fourth quarter valued at $28,000. Caitong International Asset Management Co. Ltd bought a new stake in Synopsys in the fourth quarter worth $28,000. Atlas Capital Advisors Inc. purchased a new stake in shares of Synopsys in the fourth quarter worth $32,000. Finally, Osbon Capital Management LLC purchased a new stake in shares of Synopsys in the fourth quarter worth $34,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Stock Performance
Shares of SNPS stock opened at $436.63 on Wednesday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company has a 50 day moving average price of $480.61 and a 200-day moving average price of $461.12. Synopsys, Inc. has a 52 week low of $376.18 and a 52 week high of $651.73. The firm has a market capitalization of $83.61 billion, a PE ratio of 101.07, a P/E/G ratio of 2.60 and a beta of 1.22.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a research note on Thursday, May 28th. Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. Bank of America upped their target price on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Finally, BNP Paribas Exane increased their price target on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $570.06.
Read Our Latest Analysis on SNPS
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 0.56% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
